Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Overcoming refractory massive proteinuria remains a clinical and research issue in diabetic nephropathy. This study was designed to investigate the pathogenesis of massive proteinuria in diabetic nephropathy, with a special focus on podocyte autophagy, a system of intracellular degradation that maintains cell and organelle homeostasis, using human tissue samples and animal models. Insufficient podocyte autophagy was observed histologically in patients and rats with diabetes and massive proteinuria accompanied by podocyte loss, but not in those with no or minimal proteinuria. Podocyte-specific autophagy-deficient mice developed podocyte loss and massive proteinuria in a high-fat diet (HFD)–induced diabetic model for inducing minimal proteinuria. Interestingly, huge damaged lysosomes were found in the podocytes of diabetic rats with massive proteinuria and HFD-fed, podocyte-specific autophagy-deficient mice. Furthermore, stimulation of cultured podocytes with sera from patients and rats with diabetes and massive proteinuria impaired autophagy, resulting in lysosome dysfunction and apoptosis. These results suggest that autophagy plays a pivotal role in maintaining lysosome homeostasis in podocytes under diabetic conditions, and that its impairment is involved in the pathogenesis of podocyte loss, leading to massive proteinuria in diabetic nephropathy. These results may contribute to the development of a new therapeutic strategy for advanced diabetic nephropathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, a high-fat diet induced minimal proteinuria in wild-type mice, but podocyte-specific Atg5-knockout mice developed substantial albuminuria accompanied by severe tubulointerstitial lesions and injury to podocytes, which accumulated damaged lysosomes.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
In the citing paper
“Another study showed that podocyte autophagy was impaired in patients with type 2 diabetes, as well as in OLETF rats (that is, rats with obesity-induced diabetes), with severe proteinuria, but not in those with no or minimal proteinuria128.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
In the citing paper
“suggesting that serum-derived factors might negatively regulate podocyte autophagy as DKD progresses128.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
In the citing paper
“Interestingly, stimulating cultured podocytes with serum from patients with type 2 diabetes or OLETF rats with severe proteinuria inhibited autophagy and induced lysosomal dysfunction and apoptosis”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [128]
Citations
Cites
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“The mammalian target of rapamycin complex 1 (mTORC1) is a nutrient-sensing signal that inhibits autophagy (49).”
BackgroundAutophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452 · cited 1×
“Autophagy is an evolutionarily conserved intracellular catabolic process that allows for the degradation of proteins and organelles via the lysosomal pathway (5,6).”
BackgroundAutophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Autophagy is an evolutionarily conserved intracellular catabolic process that allows for the degradation of proteins and organelles via the lysosomal pathway (5,6).”
BackgroundPankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 1×
“The protein p62 is a specific target of the autophagy degradation; thus, intracellular accumulation of this protein is indicative of insufficient autophagy (37).”
BackgroundMethods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497 · cited 1×
“Complement was depleted by heat inactivation, and cells were incubated in 10% serum for 24 h (29,30), with/without lysosome inhibitors for 1 h (31).”
MethodAutophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506 · cited 1×
“Autophagy can degrade many damaged proteins and organelles (7).”
BackgroundThe role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 3×
“The protein coded by the Atg5 gene is essential for autophagosome formation (21).”
BackgroundImpairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Glomeruli of podocyte-specific Atg7deficient (33,34) and wild-type mice were isolated using Dynabeads M-450 Tosylactivated (Invitrogen, Carlsbad, CA) (35).”
BackgroundMethodMizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105 · cited 2×
“Interestingly, autophagy activity in podocytes is constitutively high, even under nonstress conditions (18,19), suggesting that the autophagylysosome system plays a pivotal role in maintaining podocyte homeostasis and that its alteration is involved in the pathogenesis of diabetic nephropathy.”
BackgroundMethodRabinowitz, J. D., & White, E. (2010) · Science · doi:10.1126/science.1193497 · Cited by 1,982
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice
Beckerman, P., Bi-Karchin, J., Park, A. S. D., Qiu, C., Dummer, P. D., Soomro, I., Boustany-Kari, C. M., Pullen, S. S., Miner, J. H., Hu, C.-A. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4287 · Cited by 344
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 292
“This evidence is supported by decreased expression of Beclin1, Atg5–Atg12, and LC3 both in podocytes of STZ-induced diabetic mice and in cells cultured in high glucose [175].”
BackgroundHan, Y.-C., Tang, S.-Q., Liu, Y.-T., Li, A.-M., Zhan, M., Yang, M., Song, N., Zhang, W., Wu, X.-Q., Peng, C.-H., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04184-8 · Cited by 257
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Yang, D., Livingston, M. J., Liu, Z., Dong, G., Zhang, M., Chen, J.-K., & Dong, Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2639-1 · Cited by 252
“1 3 negatively regulate podocyte autophagy through serum factor-dependent intracellular signaling pathways in the progression of DKD [127].”
BackgroundInfluentialAutophagy and kidney inflammation
Kimura, T., Isaka, Y., & Yoshimori, T. (2017) · Autophagy · doi:10.1080/15548627.2017.1309485 · Cited by 224
“induces hyperglycemia with proteinuria, damages podocytes in podocyte-specific autophagy-deficient mice.(47) Autophagy also contributes to the degradation of AGEs,(48,49) and thus suppresses inflammation in kidney.”
Backgroundp53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
Ma, Z., Li, L., Livingston, M. J., Zhang, D., Mi, Q., Zhang, M., Ding, H.-F., Huo, Y., Mei, C., & Dong, Z. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135536 · Cited by 220
Packer, M. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.04.016 · Cited by 214
Diabetic Nephropathy: a Tangled Web to Unweave
Magee, C., Grieve, D. J., Watson, C. J., & Brazil, D. P. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6755-9 · Cited by 190
“cant proteinuria, whilst also confirming the lack of autophagy in renal biopsy tissue, which displayed intra-cellular accumulation of p62, a specific autophagy target [128].”
BackgroundAutophagy in Chronic Kidney Diseases
Lin, T.-A., Wu, V. C.-C., & Wang, C.-Y. (2019) · Cells · doi:10.3390/cells8010061 · Cited by 188
“These suggest that the insufficient autophagic function could cause podocytes injury in diabetic nephropathy with severe proteinuria [58].”
BackgroundShukla, L., Yuan, Y., Shayan, R., Greening, D. W., & Karnezis, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00158 · Cited by 179
Acute Kidney Injury and Progression of Diabetic Kidney Disease
Yu, S. M.-W., & Bonventre, J. V. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.005 · Cited by 175
Update on diagnosis, pathophysiology, and management of diabetic kidney disease
Sugahara, M., Pak, W. L. W., Tanaka, T., Tang, S. C. W., & Nangaku, M. (2021) · Nephrology · doi:10.1111/nep.13860 · Cited by 171
“ealed greater podocyte loss and massive proteinuria after high-fat feeding.(42) The mechanism of dysregulated autophagy in DKD is not”
BackgroundChoi, M. E. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034658 · Cited by 150
Autophagy in kidney disease and aging: lessons from rodent models
Lenoir, O., Tharaux, P.-L., & Huber, T. B. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.014 · Cited by 148
Hu, S., Hang, X., Wei, Y., Wang, H., Zhang, L., & Zhao, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01502-3 · Cited by 166
“Podocyte autophagy, a type II programmed cell death, plays a critical role in the pathogenesis of podocyte loss, leading to extensive proteinuria in DKD [66].”
BackgroundGuo, Y., Lin, C., Xu, P., Wu, S., Fu, X., Xia, W., & Yao, M. (2016) · Scientific Reports · doi:10.1038/srep36416 · Cited by 142
“It has been reported that insufficient podocyte autophagy was involved in the pathogenesis of podocytes loss and led to massive proteinuria by high-fat diet in Atg5 deficient mice 26 .”
BackgroundPodocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
Li, X., Zhang, Y., Xing, X., Mi, L., Liu, Y., Xu, A., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115670 · Cited by 158
Barutta, F., Bellini, S., Kimura, S., Hase, K., Corbetta, B., Corbelli, A., Fiordaliso, F., Bruno, S., Biancone, L., Barreca, A., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2080382 · Cited by 141
Packer, M. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010010 · Cited by 123
Bai, X., Geng, J., Li, X., Wan, J., Liu, J., Zhou, Z., & Liu, X. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7278 · Cited by 127
“Podocyte apoptosis and injury have also been confirmed in the pathological study of DN in humans (29).”
Takahashi, A., Takabatake, Y., Kimura, T., Maejima, I., Namba, T., Yamamoto, T., Matsuda, J., Minami, S., Kaimori, J.-Y., Matsui, I., et al. (2017) · Diabetes · doi:10.2337/db16-0397 · Cited by 122
“With regard to the role of autophagy in diabetic nephropathy, it has been reported that autophagy in podocytes plays a protective role by maintaining lysosomal homeostasis (23).”
BackgroundMitochondria in Diabetic Kidney Disease
Ahmad, A. A., Draves, S. O., & Rosca, M. G. (2021) · Cells · doi:10.3390/cells10112945 · Cited by 126
Lu, Z., Liu, H., Song, N., Liang, Y., Zhu, J., Chen, J., Ning, Y., Hu, J., Fang, Y., Teng, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04156-y · Cited by 128
Ryter, S. W., Bhatia, D., & Choi, M. E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7518 · Cited by 114
Wang, X., Gao, L., Lin, H., Song, J., Wang, J., Yin, Y., Zhao, J., Xu, X., Li, Z., & Li, L. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.009 · Cited by 114
“Podocyte-specific autophagy-deficient mice developed podocyte loss and massive proteinuria (Tagawa et al., 2016).”
BackgroundInfluentialAutophagy: A Novel Therapeutic Target for Diabetic Nephropathy
Kume, S., & Koya, D. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.451 · Cited by 115
“However, two recent works, including our own, have clearly shown the renoprotective role of autophagy in diabetic podocytes [38,39].”
BackgroundResultInfluentialSelf-citationPacker, M. (2020) · Circulation · doi:10.1161/circulationaha.119.045561 · Cited by 115
Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases
Zhang, W., Li, X., Wang, S., Chen, Y., & Liu, H. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0265-4 · Cited by 119
Korbut, A. I., Taskaeva, I. S., Bgatova, N. P., Muraleva, N. A., Орлов, Н. Б., Dashkin, M. V., Khotskina, А. S., Zavyalov, E. L., Konenkov, V. I., Klein, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082987 · Cited by 119
Guo, H., Wang, Y., Zhang, X., Zang, Y., Zhang, Y., Wang, L., Wang, H., Wang, Y., Cao, A., & Peng, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07061-7 · Cited by 104
Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0879-y · Cited by 108
Self-citationPodocytes maintain high basal levels of autophagy independent of mtor signaling
Bork, T., Liang, W., Yamahara, K., Lee, P., Tian, Z., Liu, S., Schell, C., Thedieck, K., Hartleben, B., Patel, K., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1705007 · Cited by 100
“towards diabetic nephropathy (DN) and focal segmental glomerulosclerosis (FSGS).(6,27,28) Furthermore, podocyte maintenance is safeguarded by the mechanistic target of rapamycin (mTOR) pathway known to inhibit autophagy.”
BackgroundSelf-citationHuang, S., Ding, D., Chen, S., Dong, C., Ye, X., Yuan, Y., Feng, Y., Na, Y., Xu, J., Miao, H., et al. (2017) · Scientific Reports · doi:10.1038/srep45692 · Cited by 104
Yang, F., Qu, Q., Zhao, C., Liu, X., Yang, P., Li, Z., Han, L., & Shi, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110479 · Cited by 100
Zhao, X., Chen, Y., Tan, X., Zhang, L., Zhang, H., Li, Z., Liu, S., Li, R., Lin, T., Liao, R., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5077 · Cited by 93
“This impaired autophagosome turnover was supported by the decreased transcript levels for the lysosomal gene Lamp1 and is consistent with Tagawa et al’s report [24].”
BackgroundResultInfluentialLiu, W. J., Gan, Y., Huang, W. F., Wu, H.-L., Zhang, X.-Q., Zheng, H. J., & Liu, H.-F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2002-6 · Cited by 88
Mazzierli, T., Allegretta, F., Maffini, E., & Allinovi, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1088031 · Cited by 88
“, 2008; Izzedine and Perazella, 2015); - interference with signal transducers, such as mTORpathway, with mTOR inhibitors (Everolimus) that interfere with endothelial cells and in particular with autophagy (a system of intracellular degradation that maintains the cell and organelle homeostasis) (Lenoir et al., 2015; Ta…”
BackgroundAutophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy
Yi, M., Zhang, L., Liu, Y., Livingston, M. J., Chen, J.-K., Nahman, N. S., Liu, F., & Dong, Z. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00114.2017 · Cited by 86
Dusabimana, T., Park, E., Je, J., Jeong, K., Yun, S. P., Kim, H. J., Kim, H., & Park, S. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041651 · Cited by 83
“Autophagy is an essential adaptive cellular response to the metabolic stress in DN, and autophagy deficiency is strongly implicated in the progression of DN [6,70].”
BackgroundRole of oxidative stress in diabetes-induced complications and their management with antioxidants
Singh, H. B., Singh, R., Singh, A., Singh, H., Singh, G., Kaur, S., & Singh, B. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2243651 · Cited by 98
“Glomerular hyperfiltration leads to DKD development. tGF-β is activated by an increase in oxidative stress, along with an increase in Ang-ii levels, which promotes the production of the mesangial matrix. the activation of NADPH oxidase by increased Ang-ii levels increased renal ROS generation. tGF-β is also implicated…”
InfluentialAutophagy Protects against Palmitic Acid-Induced Apoptosis in Podocytes in vitro
Jiang, X.-S., Chen, X., Wan, J., Gui, H.-B., Ruan, X. Z., & Du, X. (2017) · Scientific Reports · doi:10.1038/srep42764 · Cited by 81
Zhong, Y., Luo, R., Liu, Q., Zhu, J., Lei, M., Liang, X., Wang, X., & Peng, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112697 · Cited by 79
Cell Apoptosis and Autophagy in Renal Fibrosis
Zhao, X., Livingston, M. J., Liang, X., & Dong, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_28 · Cited by 77
NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy
Hou, Y., Lin, S., Qiu, J., Sun, W., Dong, M., Xiang, Y., Wang, L., & Du, P. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.194 · Cited by 79
Zhong, Y., Liu, J., Sun, D., Guo, T., Yao, Y., Xia, X., Shi, C., & Peng, X. (2022) · Food & Function · doi:10.1039/d1fo02733f · Cited by 77
Wang, X., Jiang, L., Liu, X., Huang, Y., Wang, A., Zeng, H.-X., Gao, L., Zhu, Q., Xia, L., & Wu, Y.-G. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154400 · Cited by 80
Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes
Liu, Y., Zhang, J., Wang, Y., & Zeng, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.414 · Cited by 74
“Therefore, it is hypothesized that apelin, which is increased in plasma in type 2 diabetes, lead to podocyte apoptosis through inhibiting podocyte autophagy, which resulted in podocyte dysfunction followed by DN. KkAy mice (diabetic mice) and cultured podocytes (MPC5 cells and native podocytes) were treated with high…”
BackgroundInfluentialExosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy
Chen, J., Zhang, Q. H., Liu, D., & Liu, Z. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154834 · Cited by 76
Yan, Q., Song, Y., Zhang, L., Chen, Z., Yang, C., Liu, S., Yuan, X., Gao, H., Ding, G., & Wang, H. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0065-2 · Cited by 72
Xu, Y., Gao, H., Hu, Y., Fang, Y., Qi, C., Huang, J., Cai, X., Wu, H., Ding, X., & Zhang, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.008 · Cited by 76
Salemkour, Y., Yildiz, D., Dionet, L., Hart, D. C. ‘., Verheijden, K. A. T., Saito, R., Mahtal, N., Delbet, J., Letavernier, E., Rabant, M., et al. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000212 · Cited by 76
“18 – 20 The molecular mechanisms underlying impaired podocyte autophagy during DKD remain elusive.”
BackgroundZhang, P., Fang, J., Zhang, J., Ding, S., & Gan, D. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s237451 · Cited by 71
The complicated role of mitochondria in the podocyte
Gujarati, N. A., Vasquez, J. M., Bogenhagen, D. F., & Mallipattu, S. K. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00393.2020 · Cited by 71
An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy
Li, K., Ji, M., & Sun, H. (2021) · Gene · doi:10.1016/j.gene.2021.145532 · Cited by 79
Sun, W., Yang, J., Wang, W., Hou, J., Cheng, Y., Fu, Y., Xu, Z., & Cai, L. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.12.005 · Cited by 69
Sun, J., Li, Z. P., Zhang, R. Q., & Zhang, H. M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.145 · Cited by 70
Lysophosphatidic Acid Signaling in Diabetic Nephropathy
Lee, J., Kim, D., Oh, Y. S., & Jun, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112850 · Cited by 78
“Reduction of autophagy induces loss of podocytes, damage in proximal tubular cells, and glomerulosclerosis [74, 75].”
BackgroundLiang, S., Wu, Y.-S., Li, D.-Y., Tang, J., & Liu, H. (2022) · Aging and Disease · doi:10.14336/ad.2021.1027 · Cited by 73
“Furthermore, cultured podocytes treated with sera from patients and rats with diabetes and massive proteinuria led to dysfunction of autophagy, causing lysosome dysfunction and podocytes apoptosis [162].”
BackgroundInfluentialReciprocal Crosstalk Between Autophagic and Endocrine Signaling in Metabolic Homeostasis
Sinha, R. A., Singh, B. K., & Yen, P. M. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1103 · Cited by 67
Xu, X., Huang, X., Zhang, L., Huang, X., Qin, Z., & Hua, F. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02391-1 · Cited by 70
“Stress-induced dysfunction, injury, and apoptosis of podocytes are critical for the pathogenesis of proteinuria and chronic nephropathy [12, 13].”
BackgroundFisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
Dong, W., Jia, C., Li, J., Zhou, Y., Luo, Y., Liu, J., Zhao, Z., Zhang, J., Lin, S., & Chen, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.783706 · Cited by 66
Kidney Aging and Chronic Kidney Disease
Zhang, Y., Chen, Y., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126585 · Cited by 86
“The impaired autophagy observed in diabetes may result in a diminished ability to remove damaged lysosomes, leading to the accumulation of advanced glycation end products (AGEs) to further disrupt lysosomal function and ultimately contributing to the progression of DKD [71].”
BackgroundDiabetes-accelerated experimental osteoarthritis is prevented by autophagy activation
Ribeiro, M. P., de Figueroa, P. L., Nogueira-Recalde, U., Centeno, A., Mendes, A. F., Blanco, F. J., & Caramés, B. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.06.019 · Cited by 63
Chen, Y., Liu, Q., Shan, Z., Mi, W., Zhao, Y., Li, M., Wang, B., Zheng, X., & Feng, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01477 · Cited by 64
Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
Zhang, L., Wen, Z., Han, L., Zheng, Y., Wei, Y., Wang, X., Wang, Q., Fang, X., Zhao, L., & Tong, X. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7504798 · Cited by 72
“[26] directly revealed the progress of podocyte autophagy in DN for the first time.”
BackgroundMitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
Apostolova, N., Vezza, T., Muntane, J., Rocha, M., & Víctor, V. M. (2023) · Antioxidants & Redox Signaling · doi:10.1089/ars.2022.0016 · Cited by 58
Kim, H., Dusabimana, T., Kim, S. R., Je, J., Jeong, K., Kang, M. C., Cho, K. M., Kim, H. J., & Park, S. W. (2018) · Nutrients · doi:10.3390/nu10111703 · Cited by 62
Yang, S., Lin, C., Zhuo, X., Wang, J., Rao, S., Xu, W., Cheng, Y., & Yang, L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2019 · Cited by 63
Sheng, H., Zhang, D., Zhang, J., Zhang, Y., Lu, Z., Mao, W., Liu, X., & Zhang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.986825 · Cited by 65
“The loss and dysfunction of podocytes are closely associated with proteinuria, the hallmark of early renal injury in DN (2), and contribute to aggravated glomerular injury and the progression of DN (3, 4).”
BackgroundHan, X., Wang, J., Li, R., Huang, M., Yue, G., Guan, L., Deng, Y., Cai, W., & Xu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054696 · Cited by 64
“Autophagy plays a crucial role in maintaining lysosome homeostasis in podocytes under diabetic conditions, and its impairment is an important pathophysiological mechanism of DKD [11].”
BackgroundNephrotic syndrome: pathophysiology and consequences
Ponticelli, C., & Moroni, G. L. (2023) · Journal of Nephrology · doi:10.1007/s40620-023-01697-7 · Cited by 76
“…eplerenone, and finerenone) may be due to different mechanisms, including the reduction of systemic and intrarenal blood pressure [28], the attenuation of aldosterone-induced renal cellular injury [29], and the increase of autophagic activity in podocytes with impaired autophagy [30].”
BackgroundRoles of mTOR in Diabetic Kidney Disease
Yasuda‒Yamahara, M., Kume, S., & Maegawa, H. (2021) · Antioxidants · doi:10.3390/antiox10020321 · Cited by 60
Self-citationLysosomal dysfunction–induced autophagic stress in diabetic kidney disease
Zheng, H., Zhang, X., Guo, J., Zhang, W., Ai, S., Zhang, F., Wang, Y., & Liu, W. J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15301 · Cited by 57
Li, X., Jiang, H., Liu, X., Liu, Y., Tang, J., Shi, J., Yu, X., Wang, X., Du, L., Lü, Q., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114675 · Cited by 55
ER stress response mediates diabetic microvascular complications
Sankrityayan, H., Oza, M. J., Kulkarni, Y. A., Mulay, S. R., & Gaikwad, A. B. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.08.003 · Cited by 54
Controversies in Podocyte Loss: Death or Detachment?
Yin, L., Lu, Y., He, C., & Chen, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.771931 · Cited by 57
“The transgenic mice with autophagy-specific deficiency in podocytes developed massive proteinuria and podocyte loss in a high-fat diet (HFD)-induced diabetic model, in which minimal proteinuria was often induced (Tagawa et al., 2016).”
BackgroundAutophagy and mitophagy: physiological implications in kidney inflammation and diseases
Bhatia, D., & Choi, M. E. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00012.2023 · Cited by 57
The protective effect and mechanism of catalpol on high glucose-induced podocyte injury
Chen, Y., Liu, Q., Shan, Z., Zhao, Y., Li, M., Wang, B., Zheng, X., & Feng, W. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2656-8 · Cited by 50
Emerging role of tumor suppressor p53 in acute and chronic kidney diseases
Overstreet, J. M., Gifford, C. C., Tang, J., Higgins, P. J., & Samarakoon, R. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04505-w · Cited by 58
“In fact, proximal tubule-specific ablation of autophagy-related gene 7 (Atg7) leads to decreased autophagy, renal hypertrophy, tubular injury, inflammation, fibrosis, and increased albuminuria in STZ-induced DKD highlighting its protective role in renal disease [101].”
BackgroundSpironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
Dong, D. F., Fan, T., Ji, Y., Yu, J., Wu, S., & Zhang, L. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02074-9 · Cited by 48
“reported that impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy [22].”
BackgroundCao, T., Xu, R., Xu, Y., Liu, Y., Qi, D., & Wan, Q. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02241-y · Cited by 48
APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease
Beckerman, P., & Suszták, K. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.05.008 · Cited by 50
Ni, Y., Wang, X., Yin, X., Li, Y., Liu, X., Wang, H., Liu, X., Zhang, J., Gao, H., Shi, B., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13816 · Cited by 47
“important role in the pathogenesis of proteinuria and the progression of chronic nephropathy.(1,2) Additionally, the F‐actin cytoskeleton has”
BackgroundLi, G., Huang, D., Hong, J., Bhat, O. M., Yuan, X., & Li, P. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00150.2019 · Cited by 50
“Beyond intracellular digestion, lysosomes may also importantly participate in the physiological regulation of cell functions or activities in many tissues or cells (4, 15, 45), including podocytes (28, 33, 48).”
BackgroundChen, D., Xu, R., Zhou, J., Chen, J., Wang, L., Liu, X., Liang, C.-L., Liu, B., Lu, R., Wu, J., et al. (2019) · Food & Function · doi:10.1039/c9fo00957d · Cited by 47
Glucose Transporters in Diabetic Kidney Disease—Friends or Foes?
Wasik, A. A., & Lehtonen, S. H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00155 · Cited by 50
“Autophagic activity, which is regulated by the above-mentioned nutrient-sensing signals, is also altered in both podocytes and proximal tubular cells under diabetic conditions (123, 124).”
BackgroundSerum level of the autophagy biomarker Beclin-1 in patients with diabetic kidney disease
Naguib, M., & Rashed, L. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.022 · Cited by 46
Basavarajappa, S. C., & Nandini, C. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.031 · Cited by 49
Autophagy in kidney disease: Advances and therapeutic potential
Bhatia, D., & Choi, M. E. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.01.008 · Cited by 52
Hou, B., Li, Y., Li, X., Zhang, C., Zhao, Z., Chen, Q., Zhang, N., & Li, H. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109744 · Cited by 48
AMPK pathway: an emerging target to control diabetes mellitus and its related complications
Kakoti, B. B., Alom, S., Deka, K., & Halder, R. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01420-8 · Cited by 54
“Defective podocyte autophagy during diabetes has been linked to modified podocyte filtration barrier activities & proteinuria [126 ].”
Liu, F., Yang, Z., Li, J., Wu, T., Li, X., Zhao, L., Wang, W., Yu, W., Zhang, G., & Xu, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01020-5 · Cited by 53
Podocyte Autophagy in Homeostasis and Disease
Lin, Q., Banu, K., Ni, Z., Leventhal, J. S., & Menon, M. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061184 · Cited by 52
“Here again, compared to control mice, podocyte-specific autophagy deficient mice (Nphs2-Cre; Atg5flox/flox) with high-fat diet developed worsened albuminuria accompanied by more severe podocyte damage [82].”
BackgroundInfluentialCell Cycle and Senescence Regulation by Podocyte Histone Deacetylase 1 and 2
Rangel, P. X. M., Cross, E., Liu, C., Pedigo, C. E., Tian, X., Gutiérrez-Calabrés, E., Nagata, S., Priyadarshini, A., Lerner, G., Bunda, P., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022050598 · Cited by 48
Liu, Y., Li, X., Zhao, M., Wu, Y., Xu, Y., Li, X., Fu, L., Han, L., Zhou, W. J., Hu, Q., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121991 · Cited by 47
Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling
Jin, J., Hu, K. Q., Ye, M., Wu, D., & He, Q. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491905 · Cited by 45
P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response
Dusabimana, T., Kim, S. R., Park, E., Je, J., Jeong, K., Yun, S. P., Kim, H. J., Kim, H., & Park, S. W. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101089 · Cited by 44
“Autophagy impairment has been implicated in the pathogenesis of DN [1,57].”
BackgroundCelastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway
Nie, Y., Fu, C., Zhang, H., Zhang, M., Xie, H., Tong, X., Li, Y., Hou, Z., Fan, X., & Yan, M. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03050-y · Cited by 43
Jain, S., Sherkhane, B., Kalvala, A. K., Arruri, V. K., Ravichandiran, V., & Kumar, A. (2022) · Cell Biology International · doi:10.1002/cbin.11899 · Cited by 43
Metadata
- Authors
- Tagawa, A., Yasuda, M., Kume, S., Yamahara, K., Nakazawa, J., Chin-Kanasaki, M., Araki, H., Araki, S.-I., Koya, D., Asanuma, K., Kim, E.-H., Haneda, M., Kajiwara, N., Hayashi, K., Ohashi, H., Ugi, S., Maegawa, H., & Uzu, T.
- Affiliations
- Shiga University of Medical Science (JP)
- Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan
- Kanazawa Medical University (JP)
- Kyoto University (JP)
- Division of Nephrology, Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo, Japan
- Asahikawa Medical University (JP)
- Ikeda Municipal Hospital (JP)
- Corresponding author
- Kume, Shinji
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-09-17
- Volume
- 65
- Issue
- 3
- Pages
- 755-767
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2179291431
- Cited by
- 315
- References
- 53
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 33 · 2023: 38 · 2022: 44 · 2021: 40 · 2020: 44 · 2019: 29 · 2018: 21 · 2017: 23 · 2016: 14 · 2015: 1
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (25713033, 26293217, 15K19511, 26670431)
- Takeda Science Foundation
- Banyu Life Science Foundation International
- Uehara Memorial Foundation
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- proteinuria, diabetic nephropathy, podocyte loss, lysosomal dysfunction, lysosomal homeostasis, high-fat diet-induced diabetes, apoptosis, diabetic serum
- MeSH terms
- Intravital Microscopy, Autophagy-Related Protein 5, Autophagy-Related Protein 7, Adult, Aged, Animals, Autophagy, Cell Line, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Humans, Kidney, Lysosomes, Male, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Microscopy, Electron, Scanning, Microtubule-Associated Proteins, Middle Aged, Proteinuria, Severity of Illness Index, Blotting, Western, RNA-Binding Proteins, Apoptosis, Mice, Knockout, Rats, Long-Evans, Microscopy, Electron, Transmission, Intracellular Signaling Peptides and Proteins, Podocytes, Mice, Rats, Young Adult, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.